And with deworming, there are stronger reasons to be willing to make moderately significant funding decisions on medium-quality evidence: another RCT would cost a lot and might not move the needle that much due to the complexity of capturing/measuring the outcomes there, while it sounds like a well-designed RCT here would be in the ~ $1MM range and could move the needle quite a bit (potentially in either direction from where I think the evidence base is currently).
And with deworming, there are stronger reasons to be willing to make moderately significant funding decisions on medium-quality evidence: another RCT would cost a lot and might not move the needle that much due to the complexity of capturing/measuring the outcomes there, while it sounds like a well-designed RCT here would be in the ~ $1MM range and could move the needle quite a bit (potentially in either direction from where I think the evidence base is currently).